Literature DB >> 10639065

Characteristics of HIV-infected men with low serum testosterone levels.

J J Kopicko1, I Momodu, A Adedokun, M Hoffman, R A Clark, P Kissinger.   

Abstract

Low levels of serum testosterone may have negative implications on morbidity in HIV-infected men. The purpose of this study was to determine demographic and clinical characteristics that predict low serum testosterone among men attending our HIV clinic. A cross-sectional study of 587 HIV-positive male patients who presented at the Louisiana State University HIV Outpatient (HOP) Clinic between August 1997 and January 1999 was conducted. Demographic and clinical characteristics were collected and analysed. Of the 587 men studied, 119 (20.3%) had a serum testosterone level below 400 ng/dl. Significantly more men with low serum testosterone levels had a presence of opportunistic infection (especially HIV wasting syndrome, oesophageal candidiasis, or dementia), CD4+ cell counts below 200 cells/mm3, or were taking megestrol acetate. Early detection of low serum testosterone will allow for expedient testosterone supplementation therapy, which could improve morbidity and quality of life for HIV-infected men.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10639065     DOI: 10.1258/0956462991913466

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials.

Authors:  Ting Zhou; Zhi-Yong Hu; Hui-Ping Zhang; Kai Zhao; Yu Zhang; Ying Li; Jia-Jing Wei; Hong-Fang Yuan
Journal:  Curr Med Sci       Date:  2018-03-15

2.  Osteopenia and osteoporosis in people living with HIV: multiprofessional approach.

Authors:  Ana Lucia Lei Munhoz Lima; Priscila Rosalba D de Oliveira; Perola Grimberg Plapler; Flora Maria D Andrea Marcolino; Eduardo de Souza Meirelles; André Sugawara; Riccardo Gomes Gobbi; Alexandre Leme Godoy Dos Santos; Gilberto Luis Camanho
Journal:  HIV AIDS (Auckl)       Date:  2011-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.